Abstract
IntroductionOxaliplatin remains the most widely used chemotherapeutic agent for treating advanced colorectal cancer but its efficacy is hampered by dose-limiting neurotoxicity manifested by a painful polyneuropathy. Oxaliplatin-induced peripheral neuropathy (OIPN)...
Published Version (Free)
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have